BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24577083)

  • 1. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
    Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
    Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.
    de Almagro MC; Goncharov T; Newton K; Vucic D
    Cell Death Dis; 2015 Jun; 6(6):e1800. PubMed ID: 26111062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
    Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
    Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.
    Bertrand MJ; Milutinovic S; Dickson KM; Ho WC; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Barker PA
    Mol Cell; 2008 Jun; 30(6):689-700. PubMed ID: 18570872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells.
    Wo L; Lu D; Gu X
    Tumour Biol; 2016 Oct; 37(10):13733-13742. PubMed ID: 27476169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8.
    Estornes Y; Toscano F; Virard F; Jacquemin G; Pierrot A; Vanbervliet B; Bonnin M; Lalaoui N; Mercier-Gouy P; Pachéco Y; Salaun B; Renno T; Micheau O; Lebecque S
    Cell Death Differ; 2012 Sep; 19(9):1482-94. PubMed ID: 22421964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
    Zhang G; Miao F; Liu K; Wu J; Xu J
    Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production.
    Vanlangenakker N; Vanden Berghe T; Bogaert P; Laukens B; Zobel K; Deshayes K; Vucic D; Fulda S; Vandenabeele P; Bertrand MJ
    Cell Death Differ; 2011 Apr; 18(4):656-65. PubMed ID: 21052097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.
    Abhari BA; Cristofanon S; Kappler R; von Schweinitz D; Humphreys R; Fulda S
    Oncogene; 2013 Jul; 32(27):3263-73. PubMed ID: 22890322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
    Ikner A; Ashkenazi A
    J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLIPR-59 regulates TNF-α-induced apoptosis by controlling ubiquitination of RIP1.
    Fujikura D; Ito M; Chiba S; Harada T; Perez F; Reed JC; Uede T; Miyazaki T
    Cell Death Dis; 2012 Feb; 3(2):e264. PubMed ID: 22297296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation.
    McComb S; Cheung HH; Korneluk RG; Wang S; Krishnan L; Sad S
    Cell Death Differ; 2012 Nov; 19(11):1791-801. PubMed ID: 22576661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spy1 induces de-ubiquitinating of RIP1 arrest and confers glioblastoma's resistance to tumor necrosis factor (TNF-α)-induced apoptosis through suppressing the association of CLIPR-59 and CYLD.
    Ding Z; Liu Y; Yao L; Wang D; Zhang J; Cui G; Yang X; Huang X; Liu F; Shen A
    Cell Cycle; 2015; 14(13):2149-59. PubMed ID: 26017671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
    Guicciardi ME; Mott JL; Bronk SF; Kurita S; Fingas CD; Gores GJ
    Exp Cell Res; 2011 Jan; 317(1):107-16. PubMed ID: 20951133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
    Moquin DM; McQuade T; Chan FK
    PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
    Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
    Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
    Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
    J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
    Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J
    Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.